Page 47 - Query Get News Today

AffaMed Therapeutics and Hanmi Pharmaceutical have entered into a licensing agreement granting AffaMed exclusive rights to develop and commercialize risuteganib in Greater China, according to a press release.

Cervical cancer is the fourth most common cancer among women, according to WHO. In 2018, it caused an estimated 311,000 deaths worldwide.

Anxiety and BMI can affect asthma control regardless of physical activity levels, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.Specifically, asthma and BMI can be considered “treatable traits” of patients with asthma that can be addressed via personalized medicine to improve the quality of life and asthma control in this population.

The Healio Editors compiled the most-read asthma news published in 2021.Highlights from the previous year include new research and a Q&A on the relationship between asthma and COVID-19 outcomes; FDA approval of tezepelumab for severe asthma; FDA approval of dupilumab for children aged 6 to 11 years with moderate to severe asthma; and more.

IOL exchange and the benefits of SMILE procedures dominated refractive surgery news in December.Check out the recent top-performing items focusing on refractive surgery on Healio/OSN.

The Healio and Endocrine Today editors have compiled the most popular thyroid news stories from 2021. Readers were most interested in foods associated with better thyroid function, molecular testing as a predictor of thyroid cancer, the association between declining thyroid-stimulating hormones and cognitive decline, and more.

The American Heart Association Scientific Sessions were held virtually Nov. 13 to 15. The event included numerous presentations of new data in cardiology.Healio spoke with several experts to discuss top takeaways from the meeting, including Sana M. Al-Khatib, MD, MHS, FHRS, from Duke University School of Medicine and Duke Clinical Research Institute; Joanna Chikwe, MD, FRCS, from Smidt Heart

Novo Nordisk announced it cannot meet demand in the U.S. for its recently approved weight-loss drug semaglutide for at least the first half of 2022.A contractor filling syringes for Wegovy pens cannot comply with Good Manufacturing Practices and has halted manufacturing and deliveries, according to a company press release. Novo Nordisk says it expects to meet U.S. demand later in 2022 and

Children and youth with more screen time had increased risk for poor mental health during the COVID-19 pandemic, according to results of a longitudinal cohort study conducted in Canada and published in JAMA Network Open.“Research by our group provided evidence that stress due to social isolation was associated with deterioration in multiple mental health domains during COVID-19,”

Compared with drug therapy, there was age-based variation in catheter ablation clinical outcomes among patients with atrial fibrillation, with the largest benefits observed in younger patients, according to new data from the CABANA trial.“The CABANA trial was the first large prospective randomized trial with extended follow-up to compare catheter ablation to drug therapy with regard to